Ceftazidimeavibactam use in children and adolescents
Open Access
- 1 January 2021
- journal article
- Published by Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy in Clinical Microbiology and Antimicrobial Chemotherapy
- Vol. 23 (2)
- https://doi.org/10.36488/cmac.2021.2.173-183
Abstract
The increasing number of infections caused by multidrug-resistant gram-negative bacteria in children is a serious problem all over the world. Ceftazidim-avibactam is a promising antimicrobial drug recently approved in Russia for use in pediatric practice. This review provides information on the possible use of ceftazidime-avibactam in children with complicated intraabdominal infections (in combination with metronidazole); complicated urinary tract infections, including pyelonephritis; hospital-acquired pneumonia, including ventilator-associated pneumonia; infections caused by aerobic gram-negative microorganisms in patients with limited choice of antibacterial therapy. Based on the data on the in vitro activity of the drug, the results of clinical studies of pharmacokinetics, safety and efficacy of ceftazidimeavibactam for the treatment of infections in children the main clinical cases in which the use of ceftazidimeavibactam in pediatric practice is most justified and appropriate are identified.Keywords
This publication has 28 references indexed in Scilit:
- Ceftazidime–Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric PatientsThe Pediatric Infectious Disease Journal, 2018
- Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2017
- Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogensDiagnostic Microbiology and Infectious Disease, 2017
- Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?Antimicrobial Agents and Chemotherapy, 2017
- Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007–2015Journal of the Pediatric Infectious Diseases Society, 2017
- Irrational Use of Antibiotics in Medicine: Crisis of Antibiotic Resistance and what We Can DoPediatric pharmacology, 2017
- Antibiotic Resistance in Modern WorldPediatric pharmacology, 2017
- Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric PatientsAntimicrobial Agents and Chemotherapy, 2016
- Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysisJournal of Infection, 2016
- Measurement and Estimation of GFR in Children and AdolescentsClinical Journal of the American Society of Nephrology, 2009